Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Lilly drops $55M for access to new class of diabetes drugs
BioPharma Dive
Thu, 06/8/17 - 09:58 pm
Eli Lilly
diabetes
dual amylin calcitonin receptor agonists
DACRAs
Key Bioscience
KBP-042
Top 10 diabetes drugs by 2016 sales
Fierce Pharma
Thu, 06/8/17 - 10:04 am
diabetes
Sanofi
Novo Nordisk
Eli Lilly
Merck
Lantus
Januvia
Victoza
Levemir
Humalog
Novolog
Invokana
Medtronic’s long-awaited ‘artificial pancreas’ makes U.S. debut
Fierce Biotech
Wed, 06/7/17 - 07:10 pm
Medtronic
devices
diabetes
artificial pancreas
MannKind inks deal to bring inhaled insulin to Brazil
Drug Delivery Business News
Thu, 06/1/17 - 02:48 pm
MannKind
Brazil
diabetes
inhaled insulin
Afrezza
Novo Nordisk seeks to include cardiovascular data in Tresiba insulin label
Drug Delivery Business News
Tue, 05/30/17 - 06:17 pm
Novo Nordisk
diabetes
FDA
Tresiba
insulin
California Lipitor plaintiffs win a chance to argue the Pfizer medication triggered their diabetes
Fierce Pharma
Mon, 05/29/17 - 11:28 am
Lipitor
Pfizer
California
diabetes
statins
Roche debuts latest blood glucose meter, savings program
Fierce Biotech
Wed, 05/24/17 - 10:52 am
Roche
devices
blood glucose monitoring
diabetes
Accu-Chek
AZ's Bydureon cleared a heart safety test, but didn't cut risks. Can it still vie with Novo?
Fierce Pharma
Tue, 05/23/17 - 08:17 am
AstraZeneca
Bydureon
diabetes
Novo Nordisk
Victoza
Nevada bill could force Sanofi, Novo and Lilly to reveal their insulin pricing secrets
Fierce Pharma
Mon, 05/22/17 - 07:48 pm
Nevada
drug pricing
Sanofi
Novo Nordisk
insulin
Eli Lilly
diabetes
Diabetes drug metformin shows promise in treating one form of autism
Fierce Biotech
Tue, 05/16/17 - 09:57 am
diabetes
metformin
autism
Fragile X syndrome
Senseonics, TypeZero unite on artificial pancreas
Fierce Biotech
Sat, 05/13/17 - 10:00 am
devices
diabetes
artificial pancreas
TypeZero
Senseonics
Sanofi inks €250M bispecific small molecule diabetes deal
Fierce Biotech
Tue, 05/9/17 - 10:20 am
Sanofi
small molecule drugs
diabetes
Exscientia
One Drop, MannKind ink partnership for connected, inhaled diabetes tech
Drug Delivery Business News
Mon, 05/8/17 - 11:29 am
One Drop
MannKind
inhaled insulin
diabetes
devices
Afrezza
Novo’s diabetes medication Victoza keeps growing, despite Lilly’s market-share creep
Fierce Pharma
Thu, 05/4/17 - 10:08 am
Novo Nordisk
Victoza
diabetes
Eli Lilly
Trulicity
Novo Nordisk launches Xultophy diabetes therapy in U.S.
Mass Device
Thu, 05/4/17 - 09:45 am
Novo Nordisk
Xultophy
diabetes
type 2 diabetes
insulin degludec
liraglutide
MannKind Hopes To Reverse Fortunes With Television Show
Seeking Alpha
Wed, 05/3/17 - 02:17 pm
MannKind
television ads
diabetes
type 2 diabetes
DTC advertising
Novo Nordisk reaches whistleblower settlement in 'white-coat' sales scheme lawsuit
Fierce Pharma
Mon, 05/1/17 - 11:43 am
Novo Nordisk
whistleblower lawsuits
diabetes
CDEs
physicians
Sanofi enjoys solid Q1, despite continuing erosion of Lantus sales in U.S.
Fierce Pharma
Sat, 04/29/17 - 10:07 am
Sanofi
earnings
diabetes
Lantus
2 Reasons Eli Lilly is Getting Crushed
Barron's
Wed, 04/26/17 - 12:00 am
Eli Lilly
earnings
Jardiance
diabetes
baricitinib
[video]Eli Lilly CEO Says Diabetes Is ‘Core Engine’ to Strategy
Bloomberg
Tue, 04/25/17 - 11:20 am
Eli Lilly
Dave Ricks
Pharma CEOs
diabetes
Pages
« first
‹ previous
…
33
34
35
36
37
38
39
40
41
…
next ›
last »